Xi Wu, Ph.D. - Publications

Affiliations: 
2000 University of Illinois at Chicago, Chicago, IL, United States 
Area:
Mathematics

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Zhang H, Chen C, Wu X, Lou C, Liang Q, Wu W, Wang X, Ding Q. Effects of 14 F9 synonymous codon variants on hemophilia B expression: alteration of splicing along with protein expression. Human Mutation. PMID 35391506 DOI: 10.1002/humu.24377  0.369
2021 Liang Q, Lin X, Wu X, Shao Y, Chen C, Dai J, Lu Y, Wu W, Ding Q, Wang X. Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factor. Human Mutation. PMID 34882887 DOI: 10.1002/humu.24312  0.345
2019 Ma S, Chen C, Liang Q, Wu X, Wang X, Wu W, Liu Y, Ding Q. Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement. Orphanet Journal of Rare Diseases. 14: 182. PMID 31340840 DOI: 10.1186/s13023-019-1144-z  0.367
2019 Xie X, Chen C, Liang Q, Wu X, Wang X, Wu W, Ding Q. Characterization of two large duplications of F9 associated with mild and severe haemophilia B, respectively. Haemophilia : the Official Journal of the World Federation of Hemophilia. PMID 30866119 DOI: 10.1111/hae.13704  0.335
2016 Zhou J, Ding Q, Wu W, Ouyang Q, Xie Y, Wu X, Lu Y, Dai J, Liang Q, Wang H, Wang X, Hu Y. Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization. Journal of Clinical Pathology. PMID 27555433 DOI: 10.1136/jclinpath-2016-203862  0.362
2015 Zhou J, Xin Y, Ding Q, Jiang L, Chen Y, Dai J, Lu Y, Wu X, Liang Q, Wang H, Wang X. Thromboelastography predicts risks of obstetric complication occurrence in (hypo)dysfibrinogenemia patients under non-pregnant state. Clinical and Experimental Pharmacology & Physiology. PMID 26510121 DOI: 10.1111/1440-1681.12509  0.358
2015 Zhou J, Ding Q, Chen Y, Ouyang Q, Jiang L, Dai J, Lu Y, Wu X, Liang Q, Wang H, Wang X. Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia. Blood Cells, Molecules & Diseases. 55: 308-15. PMID 26460252 DOI: 10.1016/j.bcmd.2015.06.002  0.349
Show low-probability matches.